Unique ID issued by UMIN | UMIN000030863 |
---|---|
Receipt number | R000035236 |
Scientific Title | A study to investigate the palliative benefit of Complex supplements for seasonal allergic conjunctivitis |
Date of disclosure of the study information | 2018/01/31 |
Last modified on | 2018/07/19 14:28:28 |
A study to investigate the palliative benefit of Complex supplements for
seasonal allergic conjunctivitis
A study to investigate the palliative benefit of Complex supplements for
seasonal allergic conjunctivitis
A study to investigate the palliative benefit of Complex supplements for
seasonal allergic conjunctivitis
A study to investigate the palliative benefit of Complex supplements for
seasonal allergic conjunctivitis
Japan |
Seasonal allergic conjunctivitis
Ophthalmology |
Others
NO
The aim of this study is to assess the palliative benefit of Complex supplements for
seasonal allergic conjunctivitis by using QOL related questionnaire scores
Safety,Efficacy
Not applicable
QOL related questionnaire scores
Combination drug(anti-allergic medicine)The number of times of
usage - time of initiation of usage
QOL related questionnaire scores(interfere with everyday activities,condition)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
No need to know
3
Treatment
Food |
Ingestion of Complex supplements (Dosage (1)) component food (8 weeks)
Ingestion of Complex supplements (Dosage (2)) component food (8 weeks)
Ingestion of Complex supplements not containing component food (8 weeks)
20 | years-old | <= |
Not applicable |
Male and Female
1) Subjects who is adults of both sexes above 20 years old
2) Subjects who competent to consent and give voluntary consent in writing with full understanding after reading briefing paper of this study aim and contents
3) Subjects with cedar pollen allergy
4) Subjects without any disease, lesion or malfunction on anterior segment of the eye
1) Subjects with systemic illness
that effects on health of the eye
2) Subjects who are in pregnancy, or lactation
3) Subjects who are receiving medical treatment except Artificial tears on local or entire body that affects the study
4) Subjects with Infectious eye disease
5) Subjects who have Systemic activity allergic disease (Asthma, Hives, Anaphylaxis etc)
6) Subjects with allergy to the food to be examined
7) Subjects who participate in other clinical trial currently, or participated in other clinical trial within 1 month prior to obtaining informed consent
8) Subjects who are under initial therapy for allergy to pollen
9) Subjects who are under treatment with medicinal product that is not anti-allergic medicine for this study, or subjects who are planning to use those medical drugs
10) Any candidates considered to be unsuitable for enrollment in the opinion of physician-in-charge
70
1st name | |
Middle name | |
Last name | Yumiko Ide |
Medical Corporation Chiseikai TOKYO CENTER CLINIC
Medical Corporation Chiseikai TOKYO CENTER CLINIC
1-1-8 Yaesu,Chuo-ku,Tokyo 103-0028,JAPAN
03-3276-6935
tccide@gmail.com
1st name | |
Middle name | |
Last name | Shigeru Imai |
CROee.INC
Evidence Division
2F YS Build. 1-13-23 Minamiikebukuro Toshima-ku, Tokyo, Japan
03-5953-2108
imai@croee.com
CROee.INC
WAKAMOTO PHARMACEUTICAL CO.,LTD.
Profit organization
NO
東京センタークリニック(東京都)
2018 | Year | 01 | Month | 31 | Day |
Unpublished
Completed
2018 | Year | 01 | Month | 29 | Day |
2018 | Year | 02 | Month | 01 | Day |
2018 | Year | 04 | Month | 02 | Day |
2018 | Year | 04 | Month | 15 | Day |
2018 | Year | 04 | Month | 17 | Day |
2018 | Year | 06 | Month | 29 | Day |
2018 | Year | 01 | Month | 17 | Day |
2018 | Year | 07 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035236
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |